ELEV
Elevation Oncology
ELEV
ELEV
Delisted
ELEV was delisted on the 22nd of July, 2025.
63 hedge funds and large institutions have $226M invested in Elevation Oncology in 2024 Q1 according to their latest regulatory filings, with 38 funds opening new positions, 13 increasing their positions, 9 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
44% more repeat investments, than reductions
Existing positions increased: 13 | Existing positions reduced: 9
29.49% more ownership
Funds ownership: 60.94% → 90.44% (+29%)
Holders
63
Holding in Top 10
3
Calls
$4K
Puts
–
Top Buyers
| 1 | +$19.9M | |
| 2 | +$17.3M | |
| 3 | +$15.7M | |
| 4 |
B
Braidwell
Stamford,
Connecticut
|
+$12.2M |
| 5 |
DGM
Darwin Global Management
St. Helier,
Jersey
|
+$12M |
Top Sellers
| 1 | -$11.9M | |
| 2 | -$5.25M | |
| 3 | -$3.12M | |
| 4 |
O
OrbiMed
New York
|
-$2.87M |
| 5 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
-$2.41M |